{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:46:37Z","timestamp":1792003597498,"version":"4.4.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaapos.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of American Association for Pediatric Ophthalmology and Strabismus"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.jaapos.2018.09.010","type":"journal-article","created":{"date-parts":[[2019,1,18]],"date-time":"2019-01-18T22:33:18Z","timestamp":1547850798000},"page":"36.e1-36.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Monotherapy of topical tacrolimus 0.03% in the treatment of vernal keratoconjunctivitis in the pediatric population"],"prefix":"10.1016","volume":"23","author":[{"given":"Sadasivan K.","family":"Samyukta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neelam","family":"Pawar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meenakshi","family":"Ravindran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fathima","family":"Allapitchai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramakrishnan","family":"Rengappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaapos.2018.09.010_bib1","doi-asserted-by":"crossref","first-page":"486","DOI":"10.4103\/0301-4738.119431","article-title":"Demographic and clinical profile of vernal keratoconjunctivitis at a tertiary eye care center in India","volume":"61","author":"Saboo","year":"2013","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.jaapos.2018.09.010_bib2","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.7164\/antibiotics.40.1249","article-title":"FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics","volume":"40","author":"Kino","year":"1987","journal-title":"J\u00a0Antibiot (Tokyo)"},{"key":"10.1016\/j.jaapos.2018.09.010_bib3","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2165\/11587010-000000000-00000","article-title":"Tacrolimus on the treatment of ocular diseases","volume":"25","author":"Zhai","year":"2011","journal-title":"BioDrugs"},{"key":"10.1016\/j.jaapos.2018.09.010_bib4","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.4049\/jimmunol.139.6.1797","article-title":"Novel immunosuppressive agent, FK506. In\u00a0vitro effects on the cloned T cell activation","volume":"139","author":"Sawada","year":"1987","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaapos.2018.09.010_bib5","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/ICO.0b013e318159afbb","article-title":"Tacrolimus ointment 0.03% in the eye for treatment of giant papillary conjunctivitis","volume":"27","author":"Kymionis","year":"2008","journal-title":"Cornea"},{"key":"10.1016\/j.jaapos.2018.09.010_bib6","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1136\/bjo.2009.172387","article-title":"Topical tacrolimus 0.03% monotherapy for vernal keratoconjunctivitis\u2014case series","volume":"94","author":"Tam","year":"2010","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jaapos.2018.09.010_bib7","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1097\/ICO.0000000000000918","article-title":"Tacrolimus in corticosteroid-refractory vernal keratoconjunctivitis","volume":"35","author":"Chatterjee","year":"2016","journal-title":"Cornea"},{"key":"10.1016\/j.jaapos.2018.09.010_bib8","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1136\/bjophthalmol-2013-304453","article-title":"Therapeutic effects of 0.1% tacrolimus eye drops for refractory allergic ocular diseases with proliferative lesion or corneal involvement","volume":"98","author":"Fukushima","year":"2014","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jaapos.2018.09.010_bib9","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S1567-5769(01)00059-5","article-title":"Tacrolimus suppressed the production of cytokines involved in atopic dermatitis by direct stimulation of human PBMC system. (Comparison with steroids)","volume":"1","author":"Sakuma","year":"2001","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jaapos.2018.09.010_bib10","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/eye.2011.75","article-title":"Topical 0.005% tacrolimus eye drops for refractory vernal keratoconjunctivitis","volume":"25","author":"Kheirkah","year":"2011","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.jaapos.2018.09.010_bib11","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1089\/jop.2009.0087","article-title":"A\u00a0randomized, placebo-controlled clinical trial of tacrolimus ophthalmic suspension 0.1% in severe allergic conjunctivitis","volume":"26","author":"Ohashi","year":"2010","journal-title":"J\u00a0Ocul Pharmacol Ther"},{"key":"10.1016\/j.jaapos.2018.09.010_bib12","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4103\/0974-9233.164616","article-title":"Tacrolimus ointment for treatment of vernal keratoconjunctivitis","volume":"23","author":"Al-Amri","year":"2016","journal-title":"Middle East Afr J Ophthalmol"},{"key":"10.1016\/j.jaapos.2018.09.010_bib13","doi-asserted-by":"crossref","first-page":"S153","DOI":"10.1016\/j.jaci.2006.11.536","article-title":"Vernal keratoconjunctivitis (VKC) treated with 0.1% FK-506 ophthalmic ointment: result of three years follow-up","volume":"119","author":"Pacharn","year":"2007","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaapos.2018.09.010_bib14","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/ni805","article-title":"Human epithelial cell trigger dendritic cell mediated allergic inflammation by producing TSLP","volume":"3","author":"Soumellis","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaapos.2018.09.010_bib15","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1167\/iovs.09-4183","article-title":"Functional role of thymic stromal lymphopoietin in chronic allergic keratoconjunctivitis","volume":"51","author":"Matsuda","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jaapos.2018.09.010_bib16","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jdermsci.2015.06.016","article-title":"Dexamethasone but not tacrolimus suppress TNF-\u03b1-induced thymic stromal lymphopoietin expression in lesional keratinocytes of atopic dermatitis model","volume":"80","author":"Mizuno","year":"2015","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.jaapos.2018.09.010_bib17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000301576","article-title":"Glucocorticoids inhibit double-stranded RNA-induced thymic stromal lymphopoietin release from keratinocytes in an atopic cytokine milieu more effectively than tacrolimus","volume":"153","author":"Le","year":"2010","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaapos.2018.09.010_bib18","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1345\/aph.1M278","article-title":"Association between exposure to topical tacrolimus or pimecrolimus and cancers","volume":"43","author":"Hui","year":"2009","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jaapos.2018.09.010_bib19","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2332\/allergolint.11-OA-0349","article-title":"Blood level of tacrolimus in patients with severe allergic conjunctivitis treated by 0.1% tacrolimus ophthalmic suspension","volume":"61","author":"Ebihara","year":"2012","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaapos.2018.09.010_bib20","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1089\/jop.2007.0083","article-title":"Pharmacokinetics and tissue distribution of tacrolimus (FK506) after a single or repeated ocular instillation in rabbits","volume":"24","author":"Fujita","year":"2008","journal-title":"J\u00a0Ocul Pharmacol Ther"},{"key":"10.1016\/j.jaapos.2018.09.010_bib21","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2165\/00002018-200831030-00001","article-title":"The US FDA \u201cblack box\u201d warning for topical calcineurin inhibitors: an ongoing controversy","volume":"31","author":"Ring","year":"2008","journal-title":"Drug Saf"},{"key":"10.1016\/j.jaapos.2018.09.010_bib22","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s11882-013-0345-0","article-title":"Use of cyclosporine A and tacrolimus in treatment of vernal keratoconjunctivitis","volume":"13","author":"Vichayanond","year":"2013","journal-title":"Curr Allergy Asthma Rep"}],"container-title":["Journal of American Association for Pediatric Ophthalmology and Strabismus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091853119300096?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091853119300096?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:23:34Z","timestamp":1761078214000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1091853119300096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S1091853119300096"],"URL":"https:\/\/doi.org\/10.1016\/j.jaapos.2018.09.010","relation":{},"ISSN":["1091-8531"],"issn-type":[{"value":"1091-8531","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Monotherapy of topical tacrolimus 0.03% in the treatment of vernal keratoconjunctivitis in the pediatric population","name":"articletitle","label":"Article Title"},{"value":"Journal of American Association for Pediatric Ophthalmology and Strabismus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaapos.2018.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Association for Pediatric Ophthalmology and Strabismus. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}